Guru Ownership Trend
Guru Analysis for Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $17.4 M.
Top institutional holders include Cliff Asness and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $8.23 M net inflow during the quarter.
Recent activity highlights Cliff Asness who dramatically increased their stake. Conversely, Chuck Royce reduced exposure by 17.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Compass Therapeutics, Inc. (CMPX)
Major holders include Cliff Asness ($7.69 M), Ken Fisher ($3.05 M), Chuck Royce ($2.93 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 7.01 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.23 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CMPX. The total reported sell value was $619,809.38.
Yes, 1 managers opened new positions in CMPX, and 3 increased their existing holdings. The total reported buy value was $8.85 M.